KOSPIMachinery454910

Doosan Robotics

₩50,800▲ 5.61%2026-11-18 close
Market Cap
₩3.3T
Turnover
₩13.6B
Volume
270K
Shares out.
64.8M
PER
—
PBR
10.2×
EPS
-₩878
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

North American solution growth, but losses persist

Doosan Robotics grew third-quarter 2026 revenue 59.1% year on year, yet operating losses have persisted for five straight quarters, making the link between sales growth and profitability the key test.

  1. 1

    Third-quarter 2026 revenue reached KRW 16.2 billion, up 59.1% year on year, while the operating loss narrowed to KRW 13.4 billion.

  2. 2

    The 2025 operating loss was KRW 59.5 billion, the fourth straight annual loss since 2022, with an operating margin of -180.3%.

  3. 3

    North America reached 55% of sales in January–September 2026, up from 27% in full-year 2025.

  4. 4

    Two national R&D projects carry about KRW 98.9 billion in total R&D spending, with standard-product commercialization targeted from 2031.

  5. 5

    Net cash fell to KRW 158.4 billion at end-September 2026, down KRW 38.7 billion from year-end 2025, and KRW 50 billion of long-term borrowings appeared.

02

Business structure

Doosan Robotics reports revenue in three groups: collaborative robot arms (ARM), automation solutions, and components and other items. For January to September 2026, the mix was 50% automation solutions, 35% collaborative robot arms and 15% other.

In full-year 2025, collaborative arms made up 56%, while automation solutions and other items were 22% each, so the solutions share has expanded quickly.

The core of the automation business is End-of-Line (EOL) work at its North American subsidiary, DRA, which packs finished products and loads them onto pallets at the last stage of a production line. DRA's third-quarter 2026 revenue was USD 6.8 million, up 27% year on year, and its EOL unit rose 55% to USD 5.0 million.

By region, North America accounted for 55% of January–September 2026 sales, followed by Korea at 28%, Europe at 14%, and APAC and other at 3%. For full-year 2025, the split was Korea 45%, North America 27%, Europe 23% and APAC and other 5%, so the revenue base has shifted markedly toward North America.

The company says it is moving away from selling standalone robot arms toward plug-and-play finished products that combine collaborative arms with software and AI functions.

Rainbow Robotics, another Korean listed robotics company, also grew revenue in the same period, yet both companies continued to post operating losses as R&D costs rose.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩10.2B-₩15.3B−150.2%
2025Q4₩13B-₩16.5B−126.5%
2026Q1₩15.3B-₩12.1B−78.9%
2026Q2₩17.7B-₩14.4B−81.6%
2026Q3₩16.2B-₩13.4B−82.9%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩45B-₩13.2B-₩12.5B−29.4%−29.3%46.4%
2023₩53B-₩19.2B-₩15.9B−36.1%−3.6%4.0%
2024₩46.8B-₩41.2B-₩36.6B−88.0%−9.1%4.8%
2025₩33B-₩59.5B-₩55.5B−180.3%−15.9%14.6%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue went from KRW 45 billion in 2022 to KRW 53 billion in 2023, an 18.0% increase that made 2023 the largest year, before falling 11.7% to KRW 46.8 billion in 2024 and 29.6% to KRW 33 billion in 2025, a second straight annual decline. Among 2022 to 2025, 2025 was the smallest year.

Operating losses were KRW 13.2 billion, KRW 19.2 billion, KRW 41.2 billion and KRW 59.5 billion across the same years, marking four straight years of operating losses with the loss widening each year. In 2024 and 2025, losses grew while sales declined, and the operating margin fell to -88.0% and then -180.3%.

Net loss attributable to controlling shareholders rose from KRW 12.5 billion in 2022 to KRW 55.5 billion in 2025, and the net loss including non-controlling interests reported the same values each year.

Operating cash outflow narrowed from KRW 43.8 billion in 2024 to KRW 17.3 billion in 2025, and the debt ratio stood at 14.6% at the end of 2025.

Quarterly revenue rose from KRW 10.2 billion in the third quarter of 2025 to KRW 13 billion, then KRW 15.3 billion and KRW 17.7 billion in the next two quarters, before falling 8.5% to KRW 16.2 billion in the third quarter of 2026.

Operating losses have run for five straight quarters since the third quarter of 2025, and the KRW 13.4 billion loss in the third quarter of 2026 was smaller than a year earlier.

Net loss attributable to controlling shareholders reached KRW 18.3 billion in the third quarter of 2026, up from KRW 12.9 billion a year earlier, and the pre-tax loss of KRW 18.6 billion exceeded the operating loss.

The combined net loss attributable to controlling shareholders over the last four quarters totals KRW 56.9 billion.

The North American EOL business drove the revenue increase, but the 2025 third-quarter comparison base included revenue from a business acquired in 2025 before the deal closed, so the comparison is not like-for-like.

05

Industry analysis

Doosan Robotics pursues two directions. One is automation demand at the end of North American production lines, and the other is physical AI collaborative robots that carry AI onboard.

Government programs, namely the K-On-Device AI Semiconductor Technology Development Program and the Robot Industry Technology Development Program, selected two of the company's projects, with total R&D spending of about KRW 98.9 billion.

One project develops next-generation collaborative robots that recognize, judge and control on site without an external PC or cloud, while the other applies intelligent welding to demanding multi-layer work.

The first applications are tacking, preheating and welding in nuclear equipment manufacturing, and the company plans to extend the work to shipbuilding, plants and defense after securing nuclear quality certification.

The company said supply could widen to secure sites where communication delays and data leakage concerns had made automation difficult. Rainbow Robotics, a peer in the same sector, also showed third-quarter revenue growth alongside operating losses.

That pattern suggests the sector is in an investment phase between expanding sales and reaching profitability. Industrial humanoid and agentic robot OS development remain before commercialization, with standard-product launch targeted from 2031.

The company's current industry position combines building a track record as a North American manufacturing automation supplier with ongoing physical AI technology development.

06

Outlook

The company expects its North American subsidiary, DRA, to grow 2026 revenue by more than 50% from the prior year. It cites continued EOL growth and the effect of expanding and relocating its facility as the basis.

However, DRA's order backlog fell to USD 9.1 million at end-September 2026 from USD 14.9 million at year-end 2025, so the order flow behind that guidance still needs confirmation.

The company plans to unveil intelligent solutions built on an agentic robot operating system in 2027, and it is also highlighting its physical AI partnership with NVIDIA.

It is pursuing next-generation collaborative arm development and industrial humanoid development on the agentic OS, supported by its own AI work-intelligence model, AI platform and data infrastructure. It also says it continues to review M&A and partnerships to secure technology.

Among the national projects, the on-device AI collaborative robot is planned for commercial launch as a standard product from 2031, after 72-hour uninterrupted field tests and international safety certification.

The welding project targets matching robot welding paths with skilled workers at 95% or more and cutting path error to within ±3mm. That technical target has not yet been verified, and whether DRA's revenue growth is confirmed in the 2026 annual report is the next checkpoint.

07

Valuation

PER
—
PBR
10.2×
ROE
-17.0%
EPS
-₩878
BPS
₩4,702
Dividend per share
₩0

Because the net loss attributable to controlling shareholders totaled KRW 56.9 billion over the last four quarters, the price-to-earnings ratio cannot be calculated. With no earnings-based multiple, the share price is compared against book value and sales.

The price-to-book ratio sits in a range carrying a large premium over net assets. Total equity fell from KRW 348.6 billion at year-end 2025 to KRW 304.8 billion at end-September 2026, so the multiple on net assets moves higher at any given share price. The dividend yield is low.

The share price appears to reflect expectations for North American solution growth and physical AI project results more than a near-term earnings recovery. Whether those expectations turn into profit will show in operating loss trends and cash flow from 2027 onward.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Sharp growth in quarterly sales

Third-quarter 2026 revenue reached KRW 16.2 billion, up 59.1% year on year, and each quarter since the first quarter of 2026 has topped KRW 15 billion. North American EOL automation sales rose 55% and led the growth.

The company said it expects its North American subsidiary's 2026 revenue to rise by more than 50% from the prior year.

Shift toward integrated solutions

The automation solutions share rose from 22% in full-year 2025 to 50% in January–September 2026. The company plans to expand in North American solutions with plug-and-play finished products that pair collaborative arms with software and AI. If sales weight moves from standalone arms to solutions, the product mix and earnings structure could change.

Government projects and cash buffer

Two national projects carry total R&D spending of about KRW 98.9 billion, with about KRW 68.1 billion from government support. Cash and equivalents stood at KRW 208.4 billion at end-September 2026, and net cash was KRW 158.4 billion. The cash buffer is cited as a basis for continuing technology development through the loss period.

09

Bear factors

Persistent operating losses

Operating losses have continued for four straight years from 2022 to 2025, reaching KRW 59.5 billion in 2025. The 2025 operating margin was -180.3%, as losses grew while sales fell to KRW 33 billion.

Net loss attributable to controlling shareholders reached KRW 18.3 billion in the third quarter of 2026, up from KRW 12.9 billion a year earlier.

Shrinking North American backlog

DRA's order backlog fell to USD 9.1 million from USD 14.9 million at the end of 2025. Third-quarter 2026 revenue declined 8.5% from the prior quarter. With North America at 55% of sales, the flow of US orders has a larger effect on group results.

Shrinking financial cushion

Net cash at end-September 2026 was KRW 158.4 billion, down KRW 38.7 billion from KRW 197.1 billion at year-end 2025. KRW 50 billion of long-term borrowings appeared, though none existed at year-end 2025. The debt ratio rose to 33.9% at end-September 2026 from 14.6% at year-end 2025.

10

Risk factors

Financial cushion

Persistent operating losses reduced net cash to KRW 158.4 billion at end-September 2026, KRW 38.7 billion lower than at year-end 2025. KRW 50 billion of long-term borrowings appeared, and total equity fell from KRW 348.6 billion at end-2025 to KRW 304.8 billion at end-September 2026. The pace of cash burn will determine how long the business transition can run without new funding.

Orders and regional concentration

North America reached 55% of January–September 2026 sales, so orders at the US unit now weigh heavily on group results. DRA's backlog was USD 9.1 million at end-September 2026, down from USD 14.9 million at year-end 2025, and third-quarter sales fell 8.5% from the prior quarter. Whether the guidance is reached depends on how fast this backlog converts into revenue.

Timing of commercialization

The two national projects total about KRW 98.9 billion in R&D spending, of which about KRW 68.1 billion is government support, yet standard-product commercialization is scheduled from 2031.

The path requires 72-hour uninterrupted field tests, international safety certification and nuclear quality certification before applications widen beyond nuclear work. Longer development periods mean R&D spending can keep weighing on operating results in the meantime.

11

What to watch next

  1. Late March 2027 (2026 annual report filing deadline)

    This is the point to check whether full-year 2026 revenue and operating loss are consistent with DRA's guidance of growth above 50%. Year-end net cash and borrowing changes are also reviewed here.

  2. Q1 2027 quarterly report deadline (May 15, 2027)

    Whether the operating loss holds near the third-quarter 2026 level and whether EOL revenue growth continues is the focus of this checkpoint.

  3. During 2027

    After the agentic robot OS-based solution launch, whether new North American solution orders show up in DRA's backlog is the point to watch.

  4. 2031 (target for standard-product commercialization of the national project)

    Completion of 72-hour uninterrupted field tests and international safety certification will determine the commercialization timeline.

12

Overall view

Doosan Robotics posted third-quarter 2026 revenue of KRW 16.2 billion, up 59.1% year on year, showing top-line growth. The growth was led by the North American EOL automation business and a larger share of automation solutions.

Operating losses, however, have continued for four straight years from 2022 and for five straight quarters through the third quarter of 2026. Net loss attributable to controlling shareholders over the last four quarters totals KRW 56.9 billion, and the third-quarter net loss was larger than a year earlier.

On the balance sheet, net cash fell from year-end 2025 and long-term borrowings appeared, while the debt ratio rose to 33.9% at end-September 2026. Strengths include sales growth, the shift toward North American solutions, and government R&D support across projects totaling about KRW 98.9 billion.

Weaknesses include persistent losses, a shrinking DRA backlog and lower net cash. The government projects are R&D support rather than revenue, and commercialization is targeted from 2031, so their direct effect on current results is limited.

The next checkpoints are DRA's revenue growth and operating margin in the 2026 annual report, and the timing of the 2027 agentic OS solution launch. This report is provided for information only and does not present an investment rating or target price.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. digitaltoday.co.kr
  2. zdnet.co.kr
  3. ebn.co.kr
  4. g-enews.com
  5. zdnet.co.kr
  6. the-pr.co.kr
  7. dailian.co.kr
  8. digitaltoday.co.kr
  9. dailian.co.kr
  10. mydaily.co.kr
  11. joongangenews.com
  12. g-enews.com
  13. bullstory.io
  14. investing.com
  15. life.sano.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis